These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2282076)

  • 1. Factors influencing the binding of calpain I to human erythrocyte inside-out vesicles.
    Lee WJ; Adachi Y; Maki M; Hatanaka M; Murachi T
    Biochem Int; 1990 Oct; 22(1):163-71. PubMed ID: 2282076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for membrane-associated calpain I in human erythrocytes. Detection by an immunoelectrophoretic blotting method using monospecific antibody.
    Hatanaka M; Yoshimura N; Murakami T; Kannagi R; Murachi T
    Biochemistry; 1984 Jul; 23(14):3272-6. PubMed ID: 6087891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phosphatidylinositol and inside-out erythrocyte vesicles on autolysis of mu- and m-calpain from bovine skeletal muscle.
    Zalewska T; Thompson VF; Goll DE
    Biochim Biophys Acta; 2004 Aug; 1693(2):125-33. PubMed ID: 15313014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes.
    Soldati L; Vezzoli G; Salardi S; Spaventa R; Barber BR; Azzani T; Bianchi G
    Biochem Biophys Res Commun; 1996 May; 222(2):572-5. PubMed ID: 8670246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance.
    Glaser T; Kosower NS
    FEBS Lett; 1986 Sep; 206(1):115-20. PubMed ID: 3019763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease.
    Inomata M; Hayashi M; Nakamura M; Saito Y; Kawashima S
    J Biol Chem; 1989 Nov; 264(31):18838-43. PubMed ID: 2553723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the calpain autoproteolysis by calpastatin and phospholipids.
    Melloni E; Michetti M; Salamino F; Minafra R; Pontremoli S
    Biochem Biophys Res Commun; 1996 Dec; 229(1):193-7. PubMed ID: 8954105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of calpain and calpastatin in the catabolism of erythrocyte-membrane proteins during anaemia in hamsters (Mesocricetus auretus) infected with Leishmania donovani.
    Sen G; Ghosal J; Biswas T
    Ann Trop Med Parasitol; 2002 Dec; 96(8):787-96. PubMed ID: 12625933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes.
    Kawasaki H; Emori Y; Suzuki K
    Arch Biochem Biophys; 1993 Sep; 305(2):467-72. PubMed ID: 8373185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets.
    Chen M; Durr J; Fernandez HL
    Biochem Biophys Res Commun; 2000 Jun; 273(1):170-5. PubMed ID: 10873581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme immunoassay of calpain I and calpastatin and its application to the analysis of human erythrocyte hemolysate.
    Takano E; Kitahara A; Kannagi R; Murachi T
    J Appl Biochem; 1984 Jun; 6(3):117-25. PubMed ID: 6094468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T; Barnoy S; Kosower NS
    Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective nuclear transport of mu-calpain.
    Mellgren RL; Lu Q
    Biochem Biophys Res Commun; 1994 Oct; 204(2):544-50. PubMed ID: 7980512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain secreted by activated human lymphoid cells degrades myelin.
    Deshpande RV; Goust JM; Hogan EL; Banik NL
    J Neurosci Res; 1995 Oct; 42(2):259-65. PubMed ID: 8568927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytosol of human erythrocytes contains a highly Ca2+-sensitive thiol protease (calpain I) and its specific inhibitor protein (calpastatin).
    Murakami T; Hatanaka M; Murachi T
    J Biochem; 1981 Dec; 90(6):1809-16. PubMed ID: 6277880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
    Kiss R; Kovács D; Tompa P; Perczel A
    Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin simultaneously binds four calpains with different kinetic constants.
    Hanna RA; Garcia-Diaz BE; Davies PL
    FEBS Lett; 2007 Jun; 581(16):2894-8. PubMed ID: 17543955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the calpain inhibitor, calpastatin, during apoptosis.
    Pörn-Ares MI; Samali A; Orrenius S
    Cell Death Differ; 1998 Dec; 5(12):1028-33. PubMed ID: 9894609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.